European health insurance systems do not routinely cover experimental stem-cell therapies for cirrhosis. Private out-of-pocket cost is standard at dedicated liver centres, ranging €3,500–8,000 per infusion. Participation in ClinicalTrials.gov- or EudraCT-registered trials may offer free or subsidised access. Some national liver foundations or transplant societies provide financial assistance to qualifying patients in sanctioned trials. United Kingdom NHS cover is limited to research protocols; private UK clinics charge similar rates to continental Europe. Patients should clarify insurance coverage and trial-eligibility financial support before committing.
Cirrhosis stem-cell treatment costs typically range €3,500–8,000 per cycle, reflecting the complexity of cell expansion, multiple infusions, and intensive hepatological monitoring required. Systemic intravenous infusion and hepatic artery catheterisation (in selected protocols) add procedural costs. Cell dose is often higher for cirrhosis than joint-specific conditions, increasing manufacturing expense. Hospital-based programmes with on-site cell facilities typically charge less than standalone private clinics. Ancillary costs — imaging, lab testing, gastroenterology evaluation, variceal screening — substantially increase total per-cycle expense. European university hospitals generally offer lower rates than private boutique providers.
האם אני מועמד? → · Liver Cirrhosis: full overview → · עלות צίרוזיס בכבד → · Cost →
בדוקה רפואית על ידי צוות העריכה של StemCellAtlas עם Dr Polina Krasenova (Haematologist · Clinical Haematology & Integrative Oncology · 15+ yrs cell therapy) של קליניקת השותף Stem Plus (סופיה), כנגד הנחיות ISSCR, FDA ו-EMA. Educational information, not medical advice; figures indicative.
רפואה רגנרטיבית מאושרת GMP בלב האיחוד האירופי — החל מ-3,000–8,000 יורו, חלק קטן ממחירי ארהב או גרמניה. פרוטוקולים מותאמים אישית למטופלים מ-50+ מדינות.
בדיקה רפואית חינם